Core C RNA Sequencing and Bioinformatics
Core C RNA Sequencing and Bioinformatics
批准号:
8853015
负责人:
JAY K KOLLS
金额:
$27.58万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-06-01 至 2020-05-31
关键词:
Advisory CommitteesAsthmaBioinformaticsBiologicalBiostatistics CoreBudgetsClinical ManagementClinical ResearchCommittee MembersDNA Sequencing FacilityDataData QualityDecision MakingDiseaseEpithelialGenerationsGoalsImmuneJob DescriptionLinkMethodsOpen Reading FramesPoliciesPoly APoly(A)+ RNAPostdoctoral FellowProceduresProcessQuality ControlRNARNA ProcessingRNA Sequence AnalysisRNA SequencesRNA SplicingRNA libraryRefractoryRelative (related person)ReportingResearch PersonnelResourcesRoleSamplingServicesSpecialistSteroidsTechniquesTissuesTranscriptTranslational ResearchUniversitiesVariantWorkbasecost effectiveflexibilityhigh standardhuman datameetingsoperationprogramstooltranscriptome sequencingtranscriptomics
中文摘要
RNA测序已经迅速发展成为转录组学的革命性工具。目前,它是一个
评估转录丰度和变体的最敏感和最全面的工具
在各种生物样本中。在这一应用中,RNA-seq核心将在
对所有项目的样本进行转录组学和生物信息学分析。
RNA-SEQ/生物信息学核心的具体目标是:
1.为每个项目提供RNA测序(RNA-seq)服务。这包括
对聚A+RNA进行测序以定量组织中的多腺苷化转录本。
2.对RNA-SEQ数据进行生物信息学分析。这将包括相对的RNA
丰度、剪接变异和非人类开放阅读框的存在。
核心功能:将用一般术语描述核心功能,然后与
上面列出的具体目标。
英文摘要
RNA sequencing has quickly evolved to be a revolutionary tool for transcriptomics. Currently, it is one
of the most sensitive and comprehensive tools for assessment of transcript abundance and variants
in various biological samples. In this application, the RNA-seq Core will perform a vital role in
performing transcriptomics and bioinformatic analyses of samples obtained from all projects.
The specific aims of the RNA-seq/Bioinformatics Core are to:
1. Perform RNA sequencing (RNA-seq) services for each of the projects. This includes
sequencing of poly A+ RNA to quantify polyadenylated transcripts in tissues.
2. Perform bioinformatic analysis of the RNA-seq data. This would include relative RNA
abundance, splice variation, and presence of non-human ORFs.
Core Function: The core functions will be described in general terms and then in relation to the
specific objectives listed above.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tulane StARR Program
-
批准号:10608042
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2021
-
负责人:JAY K KOLLS
-
依托单位:
Tulane StARR Program
-
批准号:10318191
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2021
-
负责人:JAY K KOLLS
-
依托单位:
Immunotherapy of KPC Infection
-
批准号:9981924
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2020
-
负责人:JAY K KOLLS
-
依托单位:
Immunotherapy of KPC Infection
-
批准号:10443796
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2020
-
负责人:JAY K KOLLS
-
依托单位:
Immunotherapy of KPC Infection
-
批准号:10227140
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2020
-
负责人:JAY K KOLLS
-
依托单位:
Immunotherapy of KPC Infection
-
批准号:10671653
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2020
-
负责人:JAY K KOLLS
-
依托单位:
CD4_T-cell_Immunity_in_the_Lung
-
批准号:10321572
-
项目类别:
-
资助金额:$86.92万
-
财政年份:2018
-
负责人:JAY K KOLLS
-
依托单位:
CD4_T-cell_Immunity_in_the_Lung
-
批准号:10559497
-
项目类别:
-
资助金额:$86.92万
-
财政年份:2018
-
负责人:JAY K KOLLS
-
依托单位:
Training in CD4 T-cell Lung Immunity
-
批准号:9804524
-
项目类别:
-
资助金额:$9.37万
-
财政年份:2018
-
负责人:JAY K KOLLS
-
依托单位:
Generation of Novel Human Monoclonals for Lung Disease
-
批准号:9250044
-
项目类别:
-
资助金额:$6.79万
-
财政年份:2016
-
负责人:JAY K KOLLS
-
依托单位:
Generation of Novel Human Monoclonals for Lung Disease
-
批准号:9128312
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2016
-
负责人:JAY K KOLLS
-
依托单位:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
-
批准号:10521311
-
项目类别:
-
资助金额:$47.95万
-
财政年份:2016
-
负责人:JAY K KOLLS
-
依托单位:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
-
批准号:9210593
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2016
-
负责人:JAY K KOLLS
-
依托单位:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
-
批准号:10375091
-
项目类别:
-
资助金额:$51.07万
-
财政年份:2016
-
负责人:JAY K KOLLS
-
依托单位:
Th17 Cytokines and Lung Immunity
-
批准号:8990110
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2015
-
负责人:JAY K KOLLS
-
依托单位:
Th17 Cytokines and Lung Immunity
-
批准号:9193101
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2015
-
负责人:JAY K KOLLS
-
依托单位:
UPITT Rheumatoid Arthritis Combined Center (UPITT RACC)
-
批准号:8932653
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2014
-
负责人:JAY K KOLLS
-
依托单位:
Novel Macrolide Th17 Inhibitors
-
批准号:8130158
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2011
-
负责人:JAY K KOLLS
-
依托单位:
Novel Macrolide Th17 Inhibitors
-
批准号:8255486
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2011
-
负责人:JAY K KOLLS
-
依托单位:
Novel Macrolide Th17 Inhibitors
-
批准号:8389005
-
项目类别:
-
资助金额:$10.49万
-
财政年份:2011
-
负责人:JAY K KOLLS
-
依托单位:
海外基金